Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19756384 | 0.79 | CXCR2 (0.37) | ALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL2984728 | 0.77 | ALDH1A1 (0.44) | ALDH1A1KDM4EMEN1CYP1A2KMT2A | |
| SCHEMBL8107102 | 0.71 | LMNA (0.40) | ALDH1A1MEN1CYP1A2KMT2A | |
| SCHEMBL9592932 | 0.71 | CA12 (0.43) | ALDH1A1MEN1CYP1A2KMT2A | |
| Hydrochloric Acid SCHEMBL4392041 | 0.71 | L3MBTL1 (0.33) | ALDH1A1L3MBTL1MEN1CYP1A2KMT2A | |
| SCHEMBL19194448 | 0.70 | DHODH (0.50) | ALDH1A1KMT2A | |
| SCHEMBL22406948 | 0.70 | SMN1; SMN2 (0.34) | ALDH1A1KDM4EMEN1CYP1A2KMT2A | |
| SCHEMBL2627833 | 0.68 | LMNA (0.45) | ALDH1A1KDM4EL3MBTL1CYP1A2 | |
| SCHEMBL1758568 | 0.67 | L3MBTL1 (0.34) | ALDH1A1KDM4EL3MBTL1MEN1CYP1A2 | |
| SCHEMBL15043749 | 0.66 | RECQL (0.58) | ALDH1A1KDM4ECYP1A2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10221128-B2 | Intermediate of preparing high-purity sulfonamide compound | ORIENTAL (LUZHOU) AGROCHEMICALS. CO., LTD. (CN) | 2019-03-05 | — | — | US | disclosed |
| US-20180201574-A1 | INTERMEDIATE OF PREPARING HIGH-PURITY SULFONAMIDE COMPOUND | ORIENTAL (LUZHOU) AGROCHEMICALS. CO., LTD. (CN) | 2018-07-19 | — | — | US | disclosed |
| US-9950997-B2 | Method for preparing high-purity sulfonamide compound, and intermediate of sulfonamide compound | ORIENTAL LUZHOU AGROCHEMICALS CO LTD (CN) | 2018-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10221128-B2 | Intermediate of preparing high-purity sulfonamide compound | STS, SULT1A1, SULT2A1 | ALDH1A1 468/4885KDM4E 2823/4885L3MBTL1 4885/4885 |
| US-20180201574-A1 | INTERMEDIATE OF PREPARING HIGH-PURITY SULFONAMIDE COMPOUND | STS, SULT1A1, SULT2A1 | ALDH1A1 468/4885KDM4E 2823/4885L3MBTL1 4885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.